CelularityCELU -9.16%31 Days Inventory is 19.39 as of Dec. 2025, which is 86% below its 10-year median of 136.89. GuruFocus rates CELU with a GF Score™ of 31/100 and a GF Value™ of $2.28 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 635 Biotechnology companies, Celularity ranks better than 80.31% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Celularity's Average Total Inventories for the
three
months ended in Dec. 2025 was $1.57 Mil. Celularity's Cost of Goods Sold for the
three
months ended in Dec. 2025 was $7.37 Mil.
Hence, Celularity's Days Inventory for the
three
months ended in Dec. 2025 was 19.39.
The historical rank and industry rank for Celularity's Days Inventory or its related term are showing as below:
CELU'
s Days Inventory Range Over the Past 10 Years
Min: 54.37 Med: 136.89 Max: 284.92
Current: 69.64
During the past 6 years, Celularity's highest Days Inventory was 284.92. The lowest was 54.37. And the median was 136.89.
CELU's Days Inventory is ranked better than 80.31% of 635
companies
in the Biotechnology industry
Industry Median: 183.23
vs CELU: 69.64
Celularity's Days Inventory
declined
from Dec. 2024 (58.23) to Dec. 2025 (19.39).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Celularity's Inventory Turnover for the
three
months ended in Dec. 2025 was 4.71.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Celularity's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.38.
Celularity (NAS:CELU) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Celularity's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Celularity's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Celularity Days Inventory Related Terms
Celularity Days Inventory Historical Data
* Premium members only.
The historical data trend for Celularity's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CELU vs GRTX, BCDA, KTTA: Days Inventory Comparison
For the Biotechnology subindustry, Celularity's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Celularity Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Celularity's Days Inventory distribution charts can be found below:
* The bar in red indicates where Celularity's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Celularity (CELU) has a Days Inventory of 19.39 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Celularity and its competitors. This is 86% below median its historical median of 136.89. Over the past decade, Celularity's Days Inventory has ranged from 54.37 to 284.92. According to the industry distribution chart, Celularity ranks #125 out of 635 companies in the Biotechnology industry, placing it in the top 19.7%.
Is Celularity's Days Inventory too high?
Celularity's current Days Inventory of 19.39 is 86% below median its 10-year median of 136.89. Over the past 10 years, this metric has ranged from a low of 54.37 to a high of 284.92. The Biotechnology industry median Days Inventory is 183.23. Celularity's value of 19.39 is 89.4% below this industry median. Based on the distribution chart, Celularity ranks #125 out of 635 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Celularity has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Celularity's Days Inventory compare to GRTX and BCDA?
According to the Biotechnology industry distribution chart, Celularity ranks #125 out of 635 companies for Days Inventory. This places Celularity in the top 20% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.23. Celularity's value of 19.39 is 89.4% below this benchmark. Historically, Celularity's own Days Inventory has ranged from 54.37 to 284.92 over the past decade. While the company's 10-year median is 136.89 vs. the industry median of 183.23, Celularity has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Celularity's current Days Inventory of 19.39 is 89.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Celularity and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Celularity's current Days Inventory is 19.39, which is 86% below median its own 10-year median of 136.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celularity stock overvalued right now?
Based on GuruFocus' analysis, Celularity (CELU) is currently considered Possible Value Trap. The stock's GF Value™ is $2.28, compared to a current price of $0.75 — trading 67.1% below its estimated fair value. The current Days Inventory is 19.39, which is 86% below median its 10-year median of 136.89 and 89.4% below the Biotechnology industry median of 183.23. Celularity's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Celularity (CELU), the current Days Inventory is 19.39 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Celularity (CELU) Overvalued in 2026?
Based on GuruFocus' analysis, Celularity stock appears to be undervalued.
The current stock price of $0.75 is trading 67.1% below its estimated GF Value™ of $2.28.
GuruFocus considers Celularity to be Possible Value Trap.
Key valuation signals for CELU:
Days Inventory: 19.39 (86% below median its 10-year median of 136.89)
GF Value™: $2.28 vs. price of $0.75 (67.1% below fair value)
Industry Position: 89.4% below the Biotechnology median (#125 of 635)
No single metric tells the full story. See the CELU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
31GF Score
Get the complete analysis for CELU
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CELU has been successfully added to your 
